Suramin interference with transforming growth factor-β inhibition of human renal cell carcinoma in culture
- 31 August 1992
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 53 (2), 195-198
- https://doi.org/10.1016/0022-4804(92)90034-w
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Differential effects of suramin on the coupling of receptors to individual species of pertussis-toxin-sensitive guanine-nucleotide-binding proteinsBiochemical Journal, 1988
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- The TGF-β family of growth and differentiation factorsCell, 1987
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from PlateletsScience, 1986
- Suramin Antiviral Therapy in the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1986
- Suramin binds to platelet‐derived growth factor and inhibits its biological activityJournal of Cellular Biochemistry, 1985
- Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor virusesCancer Letters, 1979
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Suramin: A potent ATPase inhibitor which acts on the inside surface of the sodium pumpBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973